Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Baldauf

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
International Journal of Clinical Pharmacology Research|January 1, 1996
Biochemical activity, pharmacokinetics and tolerability of tepoxalin, a cyclooxygenase/5-lipoxygenase inhibitor, in manM Depré, A Van Hecken, R Verbesselt, et al.
Bioorganic & Medicinal Chemistry|September 1, 2000
The discovery of 4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1 ,5-a]-pyrimidine: a corticotropin-releasing factor (hCRF1) antagonistP J Gilligan, C Baldauf, A Cocuzza, et al.
Cell Death & Disease|February 12, 2019
Targeting the CALCB/RAMP1 axis inhibits growth of Ewing sarcomaMarlene Dallmayer, Jing Li, Shunya Ohmura, et al.
Oncotarget|February 9, 2018
Robust diagnosis of Ewing sarcoma by immunohistochemical detection of super-enhancer-driven EWSR1-ETS targetsMichaela C Baldauf, Martin F Orth, Marlene Dallmayer, et al.
Blood|April 28, 2021
MondoA drives malignancy in B-ALL through enhanced adaptation to metabolic stressAlexandra Sipol, Erik Hameister, Busheng Xue, et al.
International Journal of Cancer|September 30, 2018
Functional genomics identifies AMPD2 as a new prognostic marker for undifferentiated pleomorphic sarcomaMartin F Orth, Julia S Gerke, Thomas Knösel, et al.
Nature Communications|November 24, 2020
Publisher Correction: Oncogenic hijacking of a developmental transcription factor evokes vulnerability toward oxidative stress in Ewing sarcomaAruna Marchetto, Shunya Ohmura, Martin F Orth, et al.
Cancers|March 14, 2020
High Specificity of BCL11B and GLG1 for EWSR1-FLI1 and EWSR1-ERG Positive Ewing SarcomaMartin F Orth, Tilman L B Hölting, Marlene Dallmayer, et al.
Nature Communications|May 17, 2020
Oncogenic hijacking of a developmental transcription factor evokes vulnerability toward oxidative stress in Ewing sarcomaAruna Marchetto, Shunya Ohmura, Martin F Orth, et al.
Oncoimmunology|September 20, 2018
Systematic identification of cancer-specific MHC-binding peptides with RAVENMichaela C Baldauf, Julia S Gerke, Andreas Kirschner, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
International Journal of Clinical Pharmacology Research|January 1, 1996
Biochemical activity, pharmacokinetics and tolerability of tepoxalin, a cyclooxygenase/5-lipoxygenase inhibitor, in manM Depré, A Van Hecken, R Verbesselt, et al.
Bioorganic & Medicinal Chemistry|September 1, 2000
The discovery of 4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1 ,5-a]-pyrimidine: a corticotropin-releasing factor (hCRF1) antagonistP J Gilligan, C Baldauf, A Cocuzza, et al.
Cell Death & Disease|February 12, 2019
Targeting the CALCB/RAMP1 axis inhibits growth of Ewing sarcomaMarlene Dallmayer, Jing Li, Shunya Ohmura, et al.
Oncotarget|February 9, 2018
Robust diagnosis of Ewing sarcoma by immunohistochemical detection of super-enhancer-driven EWSR1-ETS targetsMichaela C Baldauf, Martin F Orth, Marlene Dallmayer, et al.
Blood|April 28, 2021
MondoA drives malignancy in B-ALL through enhanced adaptation to metabolic stressAlexandra Sipol, Erik Hameister, Busheng Xue, et al.
International Journal of Cancer|September 30, 2018
Functional genomics identifies AMPD2 as a new prognostic marker for undifferentiated pleomorphic sarcomaMartin F Orth, Julia S Gerke, Thomas Knösel, et al.
Nature Communications|November 24, 2020
Publisher Correction: Oncogenic hijacking of a developmental transcription factor evokes vulnerability toward oxidative stress in Ewing sarcomaAruna Marchetto, Shunya Ohmura, Martin F Orth, et al.
Cancers|March 14, 2020
High Specificity of BCL11B and GLG1 for EWSR1-FLI1 and EWSR1-ERG Positive Ewing SarcomaMartin F Orth, Tilman L B Hölting, Marlene Dallmayer, et al.
Nature Communications|May 17, 2020
Oncogenic hijacking of a developmental transcription factor evokes vulnerability toward oxidative stress in Ewing sarcomaAruna Marchetto, Shunya Ohmura, Martin F Orth, et al.
Oncoimmunology|September 20, 2018
Systematic identification of cancer-specific MHC-binding peptides with RAVENMichaela C Baldauf, Julia S Gerke, Andreas Kirschner, et al.
Pageof 5